Here you will find financial news and reports from APONTIS PHARMA as well as other publications relevant to the capital market.

APONTIS PHARMA publications in detail and up to date

developAd-hoc-Releases

  • 2021‑05‑06 | DGAP-Ad-hoc

    APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share

    APONTIS PHARMA AG / Key word(s): IPO APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share 06-May-2021 / 20:07 CET/CEST Disclosure of a...

    Read more...

developCorporate News

  • 2021‑09‑14 | DGAP-News

    APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and ...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Product Launch 14.09.2021 / 07:30 The issuer is solely responsible for the content of this announcement. Read more...

    2021‑08‑11 | DGAP-News

    APONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary figur...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Half Year Results/Half Year Report 11.08.2021 / 07:30 The issuer is solely responsible for the content of ...

    Read more...
    2021‑07‑28 | DGAP-News

    APONTIS PHARMA reports accelerated growth in first half of 2021 - Single Pill revenues +83% to EUR 1...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Preliminary Results/Half Year Results 28.07.2021 / 07:30 The issuer is solely responsible for the content ...

    Read more...
    2021‑07‑12 | DGAP-News

    APONTIS PHARMA marks further success in the roll-out of Single Pill therapy

    DGAP-News: APONTIS PHARMA AG / Key word(s): Alliance 12.07.2021 / 07:30 The issuer is solely responsible for the content of this announcement. ...

    Read more...
    2021‑06‑18 | DGAP-News

    APONTIS PHARMA AG: Initial studies confirm that the share has a price potential of between 77% and 1...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Research Update 18.06.2021 / 07:30 The issuer is solely responsible for the content of this announcement.<...

    Read more...
    2021‑06‑10 | DGAP-News

    APONTIS PHARMA AG: Post-Stabilisation disclosure - Partial exercise of the Greenshoe Option

    DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 10.06.2021 / 21:23 The issuer is solely responsible for the content of this announcement. Read more...

    2021‑06‑10 | DGAP-News

    APONTIS PHARMA AG: Notification on the implementation of stabilization measures

    DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 10.06.2021 / 21:20 The issuer is solely responsible for the content of this announcement. Read more...

    2021‑05‑28 | DGAP-News

    APONTIS PHARMA AG: Notification on the implementation of stabilization measures

    DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 28.05.2021 / 20:05 The issuer is solely responsible for the content of this announcement. Read more...

    2021‑05‑20 | DGAP-News

    APONTIS PHARMA AG Trading Update: Strong revenues and earnings growth with Single Pills continues i...

    DGAP-News: APONTIS PHARMA AG / Key word(s): Quarterly / Interim Statement 20.05.2021 / 07:30 The issuer is solely responsible for the content of this ...

    Read more...
    2021‑05‑19 | DGAP-News

    APONTIS PHARMA AG: Notification on the implementation of stabilization measures

    DGAP-News: APONTIS PHARMA AG / Key word(s): Miscellaneous 19.05.2021 / 20:23 The issuer is solely responsible for the content of this announcement. Read more...

    2021‑05‑14 | EQS-News

    Apontis Pharma (APPH): Initiation - A phoenix rises

    Edison Investment Research Limited 14-May-2021 / 07:00 GMT/BST

    Read more...

developFinancial Reports

  • 2021‑08‑11

    Half-yearly financial statements 2021

    PDF
    2021‑06‑28

    Annual financial statements 2020

    PDF

developCompany Presentation

  • 2021‑08‑11

    H1 Results Presentation

    PDF

developFinancial Calendar

  • February, 2021

    2020 Annual Report

    April, 2021

    Annual General Meeting 2021

    Jul 28, 2021

    Preliminary half-year figures

    Aug 11, 2021

    Publication of half-year financial statements / Conference call 14.00 CST

    Aug 26, 2021

    Hamburger Investorentag (HIT)
    Hamburg

    September, 2021

    Roadshow

    Sep 06, 2021

    Equity Forum German Fall Conference
    Frankfurt/Main

    November, 2021

    Quarterly Statement 9M 2021

    Nov 22, 2021

    German Equity Forum
    Frankfurt/Main

    Dec 07, 2021

    Münchner Kapitalmarkt Konferenz MKK
    Munich

developManagers' Transactions

  • There are no current managers’ transactions available.

developOther mandatory notifications


There are no other mandatory notifications available.
CONTACT INVESTOR RELATIONS

We look forward to your message

Do not miss any publications or news about APONTIS PHARMA AG. By registering for our IR mailings, you will always stay informed.